Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

DaVita Closes Deal to Provide Dialysis Services in Taiwan



  DaVita Closes Deal to Provide Dialysis Services in Taiwan

                         Deal Marks Entry into Taiwan

Business Wire

DENVER & TAIPEI, Taiwan -- January 20, 2013

DaVita®, the kidney care division of DaVita HealthCare Partners Inc. (NYSE:
DVA) and a leading provider of kidney care services, today announced the
formation of a joint venture with Riches Healthcare (RHC), through which a new
entity – DaVita Taiwan – will provide services to four dialysis clinics.
DaVita will own a majority share of the joint venture entity.

"Expanding our presence into Taiwan is a key step in our long-term growth
strategy in Asia," said Dennis Kogod, chief operating officer at DaVita.

The four clinics currently serviced by RHC are located in and around Taipei,
have a combined number of 88 stations and are providing hemodialysis
treatments to more than 250 patients.

“This acquisition is an exciting opportunity not only to expand into Taiwan,
but also to do so with a well-respected and highly experienced team,” said
Atul Mathur, president of Asia Pacific at DaVita. “With the addition of this
JV, DaVita is now serving patients in five countries across the Asia Pacific
region.”

As a leading provider of kidney care services in the United States, DaVita has
achieved clinical outcomes that have improved year-over-year for more than a
decade and plans to bring that track record of sustained clinical excellence
to Taiwan.

For more information on DaVita please visit www.DaVita.com.

DaVita® is a registered trademark, and DaVita HealthCare Partners is a service
mark, of DaVita HealthCare Partners Inc. All other marks are the property of
their respective owners.

About DaVita

DaVita is the dialysis division of DaVita HealthCare Partners ^ Inc., a
Fortune 500® company. A leading provider of kidney care in the United States,
DaVita delivers dialysis services to patients with chronic kidney failure and
end stage renal disease. DaVita strives to improve patients’ quality of life
by innovating clinical care, and by offering integrated treatment plans,
personalized care teams and convenient health-management services. As of Sept.
30, 2012, DaVita operated or provided administrative services at 1,912
outpatient dialysis centers located in the United States serving approximately
150,000 patients. The company also operated 24 outpatient dialysis centers
located in five countries outside the United States. DaVita supports numerous
programs dedicated to creating positive, sustainable change in communities
around the world. The company’s leadership development initiatives and social
responsibility efforts have been recognized by Fortune, Modern Healthcare,
Newsweek and WorldBlu.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of the
federal securities laws, including statements related to prospective near-term
and long-term growth, development, strategy and expectations for certain of
our international operations, anticipated patient benefits and projected
clinical outcomes. Factors which could impact future results include the risks
and uncertainties associated with expansion of our operations and services to
markets outside the United States, local laws and regulations, general
economic and other market conditions, competition, and the risk factors set
forth in our SEC filings, including our Annual Report on Form 10-K for the
year ended December 31, 2011, and our subsequently filed Quarterly Reports on
Form 10-Q. The forward-looking statements should be considered in light of
these risks and uncertainties. We base our forward-looking statements on
information currently available to us at the time of this release, and we
undertake no obligation to update or revise any forward-looking statements,
whether as a result of changes in underlying factors, new information, future
events or otherwise.

Contact:

DaVita
Skip Thurman, 303-876-6610
Mobile: 720-300-0041
Skip.Thurman@davita.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement